Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 19 most recent Form 4 transactions.
| Jan 9 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 243 | $28.50 | $6.9K | -0.1% | Open the original filing on SEC.gov |
| Jan 9 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 48,057 | $27.98 | $1.3M | -18.3% | Open the original filing on SEC.gov |
| Dec 8, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 1,705 | $21.78 | $37.1K | -0.6% | Open the original filing on SEC.gov |
| Dec 8, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 4,958 | $20.76 | $102.9K | -1.8% | Open the original filing on SEC.gov |
| Nov 7, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 613 | $17.94 | $11K | -0.2% | Open the original filing on SEC.gov |
| Nov 7, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 6,054 | $17.35 | $105K | -2.2% | Open the original filing on SEC.gov |
| Oct 7, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 6,667 | $20.10 | $134K | -2.4% | Open the original filing on SEC.gov |
| Sep 8, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 6,667 | $20.24 | $135K | -2.3% | Open the original filing on SEC.gov |
| Aug 7, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 405 | $18.93 | $7.7K | -0.1% | Open the original filing on SEC.gov |
| Aug 7, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 6,262 | $18.20 | $113.9K | -2.1% | Open the original filing on SEC.gov |
| Jul 7, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 305 | $20.69 | $6.3K | -0.1% | Open the original filing on SEC.gov |
| Jul 7, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 6,362 | $19.75 | $125.6K | -2.1% | Open the original filing on SEC.gov |
| Jun 9, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 60 | $21.16 | $1.3K | <0.1% | Open the original filing on SEC.gov |
| Jun 9, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 6,607 | $20.33 | $134.3K | -2.1% | Open the original filing on SEC.gov |
| May 7, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 104 | $19.87 | $2.1K | <0.1% | Open the original filing on SEC.gov |
| May 7, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 390 | $19.40 | $7.6K | -0.1% | Open the original filing on SEC.gov |
| May 7, 2025 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 6,173 | $18.30 | $112.9K | -1.9% | Open the original filing on SEC.gov |